BRAF and neoplasm: Growth inhibition by hyper-activated Erk due to inhibited PP2A may imply that canonical oncogenes and tumor suppressors may exchange roles in the mutated B-Raf cellular context, with the Erk oncogene playing the role of a tumor suppressor, and the PP2A tumor suppressor acting as oncogene.